You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 4, April 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Psychiatry, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Placebo Problem Remains

Arch Gen Psychiatry. 2000;57:321-322.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

NEW MEDICINES for which a manufacturer seeks market approval are usually tested against placebo, irrespective of whether effective treatment already exists for the condition. This is a requirement set forth by the US Food and Drug Administration (FDA).1 The FDA maintains that placebo-controlled trials are necessary for an easy comparison of the new drug with "nothing," whereas evaluating therapeutic equivalence of a new vs an old medication is more problematic.2 Many patients in clinical trials are therefore deprived of effective medications. A few years ago, my colleague Ken Rothman and I drew attention to this unethical use of placebo controls.3 If effective therapy exists, the physician has an ethical and legal obligation to provide it to the patient according to ethical standards that are laid out in the Declaration of Helsinki.4 The Declaration of Helsinki mandates that a new drug be compared with the best available treatment, thus placing the . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ethical aspects of placebo groups in pain trials: Lessons from psychiatry
Nagasako and Kalauokalani
Neurology 2005;65:S59-S65.
ABSTRACT | FULL TEXT  

Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh et al.
JAMA 2002;287:1840-1847.
ABSTRACT | FULL TEXT  

The Undiscovered Mind: How the Human Brain Defies Replication, Medication, and Explanation
FORREST
Am. J. Psychiatry 2002;159:333-334.
FULL TEXT  

Pharmacologic Treatment of Traumatized Children
COHEN
Trauma Violence Abuse 2001;2:155-171.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.